% | $
Quotes you view appear here for quick access.

Santarus, AŞ Message Board

  • gobathiho gobathiho Oct 4, 2012 12:46 PM Flag

    SP raises revenue estimate potential for diabetes drug makers

    looking at revenue going from 35b to 58 billion in the next few years as unfortunately diabetes diagnosis skyrocket......go Glumetza and SNTS.....the BULL is back....look for Rhuconist update in late Oct. and then earnings report with increased revenue numbers for next year followed by UCERIS labeling info in Dec.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies